medroxyprogesterone acetate has been researched along with Genetic Predisposition in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crandall, CJ; Handelman, SK; Hovey, KM; Jackson, RD; Nassir, R; Nie, J; Ochs-Balcom, HM; Preus, L; Sucheston-Campbell, LE; Wactawski-Wende, J; Wang, Y | 1 |
| Frank, LA; Watson, JB | 1 |
| Blanco, MA; Bronson, RT; Chakrabarti, R; Chekmareva, M; Guo, F; Haffty, BG; Hua, Y; Kang, Y; Lu, X; Shen, M; Smith, HA; Wan, L; Wei, Y; Wu, H; Xing, Y; Yuan, M; Yuan, S | 1 |
| Batur, P; Moore, HC; Thacker, HL | 1 |
| Danby, FW | 1 |
| Chapman, W; Fyles, A; Gowing, K; Khokha, R; Li, M; Manoukian, AS; Tsao, MS; Wood, G | 1 |
1 trial(s) available for medroxyprogesterone acetate and Genetic Predisposition
| Article | Year |
|---|---|
Treatment of alopecia X with medroxyprogesterone acetate.
Topics: Alopecia; Animals; Antineoplastic Agents, Hormonal; Dog Diseases; Dogs; Female; Genetic Predisposition to Disease; Hair; Male; Medroxyprogesterone Acetate | 2013 |
5 other study(ies) available for medroxyprogesterone acetate and Genetic Predisposition
| Article | Year |
|---|---|
Gene-Hormone Therapy Interaction and Fracture Risk in Postmenopausal Women.
Topics: Aged; Bone Density; Contraceptive Agents, Female; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Fractures, Bone; Gene-Environment Interaction; Genetic Predisposition to Disease; Genotype; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Proportional Hazards Models; United States; White People | 2017 |
MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Breast Neoplasms; Cell Adhesion Molecules; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Cell Transformation, Viral; Endonucleases; Female; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease; HEK293 Cells; Humans; Mammary Glands, Animal; Mammary Tumor Virus, Mouse; Medroxyprogesterone Acetate; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Neoplasm Invasiveness; Neoplastic Stem Cells; Nuclear Proteins; Phenotype; Protein Binding; RNA Interference; RNA-Binding Proteins; Time Factors; Transfection; Tumor Cells, Cultured | 2014 |
Discussing breast cancer and hormone replacement therapy with women.
Topics: Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Genetic Predisposition to Disease; Humans; Medroxyprogesterone Acetate; Models, Statistical; Patient Education as Topic; Postmenopause; Progesterone Congeners; Prognosis; Randomized Controlled Trials as Topic; Research Design; Risk Assessment | 2002 |
HT and WHI: the baby and the bathwater.
Topics: Blood Coagulation Factors; Breast Neoplasms; Contraceptive Agents, Female; Estradiol; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Genetic Predisposition to Disease; Humans; Medroxyprogesterone Acetate; Mutation; Progesterone; Thrombosis | 2004 |
Neither ovariectomy nor progestin treatment prevents endometrial neoplasia in pten+/- mice.
Topics: Animals; Disease Models, Animal; Endometrial Neoplasms; Female; Genetic Predisposition to Disease; Immunohistochemistry; Male; Medroxyprogesterone Acetate; Mice; Mice, Inbred C57BL; Ovariectomy; PTEN Phosphohydrolase | 2008 |